About the Company
Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health. The Company has built a proprietary product platform to enable the rapid and cost-efficient discovery and development of novel Microbiome Metabolic Therapies (MMT™). MMTs are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the gut's existing microbes. Kaleido is advancing a broad pipeline of MMT candidates with the potential to address a variety of diseases and conditions with significant unmet patient needs.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $KLDO News
Kaleido Biosciences (OTC: KLDO)
Kaleido Biosciences, Inc. is a clinical-stage healthcare company, which engages in the provision of healthcare services. It focuses on leveraging the microbiome organ to treat disease and improve ...
Kaleido Biosciences gets grant for glycan therapeutic preparation for reducing gastrointestinal inflammation in immune imbalance
Discover how Kaleido Biosciences Inc's patented method using glycan therapeutics can reduce inflammation in gastrointestinal diseases with immune imbalances, offering new treatment options.
Kaleido Biosciences Inc KLDO
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Flagship Ventures Fund 2007, L.P.'s Net Worth
Who is Flagship Ventures Fund 2007, L.P.? Flagship Ventures Fund 2007, L.P. has an estimated net worth of $280 Million. This is based on reported shares across multiple companies, which include ...
Xeno Biosciences Announces New CEO and Financing
Xeno Biosciences Inc., a clinical stage drug discovery and development company advancing therapeutics for the treatment of obesity and metabolic disea ...
ASMB Assembly Biosciences, Inc.
Assembly Biosciences, Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company’s ...
Evofem Biosciences, Inc. (EVFM)
Commercial-stage women's health innovator Evofem Biosciences, Inc. (OTCQB: EVFMD) today announced that it has successfully renegotiated the rebate for Phexxi® (lactic acid, citric acid and ...
IGM Biosciences Announces Refocusing of Sanofi Collaboration
IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that the Company’s exclusive worldwide collaboration ...
Pacira BioSciences Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Kaleido Biosciences, Inc. (KLDO)
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Loading the latest forecasts...